Qiang-Yuan Liu

Title: Qiang-Yuan Liu: Innovator in Human LXRα Variants

Introduction

Qiang-Yuan Liu is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of biotechnology, particularly through his work on human LXRα variants. His innovative approach has led to advancements that hold promise for therapeutic and diagnostic applications.

Latest Patents

Qiang-Yuan Liu holds a patent for "Human LXRα variants." This invention provides novel human LXRα variant polypeptides and nucleic acids encoding such polypeptides. The patent emphasizes the therapeutic, diagnostic, and research utilities of these polynucleotides and polypeptides. It is important to note that the abstract is provided to comply with the rules requiring a summary that allows readers to quickly ascertain the subject matter of the technical disclosure. The submission is made with the understanding that it will not be used to interpret or limit the scope or meaning of the claims, as per 37 CFR 1.72(b).

Career Highlights

Qiang-Yuan Liu is currently associated with Wyeth, a company known for its focus on pharmaceuticals and biotechnology. His work at Wyeth has allowed him to explore and develop innovative solutions in the field of human health.

Collaborations

Qiang-Yuan Liu collaborates with Ponnal Nambi, contributing to the advancement of their shared research interests and projects.

Conclusion

Qiang-Yuan Liu's contributions to the field of biotechnology, particularly through his patent on human LXRα variants, highlight his role as an innovator. His work continues to pave the way for future advancements in therapeutic and diagnostic applications.